No Data
No Data
GENSCRIPT BIO (01548.HK) exercises the conversion rights of the convertible Bonds issued by Probio Cayman.
Gelonghui, December 20 - GENSCRIPT BIO (01548.HK) announced that the company's indirect non-wholly-owned subsidiary, Probio Technology Limited ("Probio Cayman"), has completed Series A financing and that the company has subscribed to the convertible Bonds issued by Probio Cayman. On December 20, 2024, based on the convertible Bonds instrument dated August 24, 2021 (as amended by the revised agreement dated December 18, 2024), the company will exercise its rights to invest $70 million.
GenScript Announces 4th Annual Biotech Global Forum in San Francisco
Quick look at the Hong Kong market | All three major Indices closed higher, the Science and Technology Index rose nearly 2%; technology, Autos, and Biotechnology stocks climbed, with Li Auto rising over 5%, and Xiaomi Group and WUXI BIO rising nearly 3%.
Many Network Technology stocks are rising, XIAOMI-W is up 2.84%, Baidu Group-SW is up 1.74%; Semiconductor stocks are all rising, HG SEMI is up 7.64%, BEKE is down 2.78%; Autos stocks are climbing, LEAPMOTOR is up 6.42%, BRILLIANCE CHI is up 6.29%;
Express News | The USA Biological Security Act was not included in the CR bill.
This week's Hong Kong stock bull | The "first domestic makeup stock" in Hong Kong! Mao Ge Ping soared over 86% in its first week of listing; Consumer encouragement policies are expected to continue to strengthen, and Lao Pu Gold has increased by over 20%.
This week, the Hang Seng Index increased by 0.53%, closing at 19,971.24 points; during the same period, the Hang Seng TECH Index rose by 0.33%, closing at 4,479.6 points; the Hang Seng China Enterprises Index increased by 0.7%, closing at 7,186.59 points.
Express News | CITIC Construction Investment: Optimistic about investment opportunities in the pharmaceutical industry in 2025, focusing on new volume and industry integration opportunities